We are live on ! Find out more
MORF

Morphic Holding, Inc. Common Stock

Delisted

MORF was delisted on the 15th of August, 2024.

103 hedge funds and large institutions have $1.13B invested in Morphic Holding, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 38 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

9% less funds holding

Funds holding: 113103 (-10)

11% less capital invested

Capital invested by funds: $1.27B → $1.13B (-$142M)

13% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 38

38% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 24

Holders
103
Holders Change
-10
Holders Change %
-8.85%
% of All Funds
1.62%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
15
Increased
33
Reduced
38
Closed
24
Calls
$486K
Puts
Net Calls
+$486K
Net Calls Change
-$661K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$223M +$896K +21,401 +0.4%
EC
2
EcoR1 Capital
California
$159M
BlackRock
3
BlackRock
New York
$73M +$679K +16,226 +0.9%
AG
4
Artal Group
Luxembourg
$66.2M +$2.72M +64,951 +4%
NHAS
5
Novo Holdings A/S
Denmark
$65.6M -$17.4M -415,635 -20%
Vanguard Group
6
Vanguard Group
Pennsylvania
$49.7M +$1.72M +41,094 +3%
State Street
7
State Street
Massachusetts
$48.2M +$9.53M +227,635 +23%
OFM
8
Omega Fund Management
Massachusetts
$48.2M
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$44.7M -$1.41M -33,710 -3%
Holocene Advisors
10
Holocene Advisors
New York
$31.4M +$18.7M +447,177 +134%
PA
11
Perceptive Advisors
New York
$30.8M -$2.9M -69,194 -8%
Federated Hermes
12
Federated Hermes
Pennsylvania
$25.3M +$13.3M +318,839 +102%
Point72 Asset Management
13
Point72 Asset Management
Connecticut
$24.8M +$6.74M +160,934 +35%
Marshall Wace
14
Marshall Wace
United Kingdom
$24.1M -$2.55M -60,873 -9%
AAA
15
Affinity Asset Advisors
New York
$18.7M +$2.78M +66,352 +17%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$17.8M -$24.2K -579 -0.1%
Wellington Management Group
17
Wellington Management Group
Massachusetts
$16.9M +$17.7M +422,146 New
DCM
18
Driehaus Capital Management
Illinois
$15.4M -$5.56M -132,956 -26%
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$14.7M +$2.43M +58,015 +19%
Ensign Peak Advisors
20
Ensign Peak Advisors
Utah
$13.3M -$872K -20,843 -6%
RCM
21
RA Capital Management
Massachusetts
$11.2M +$11.7M +278,874 New
Morgan Stanley
22
Morgan Stanley
New York
$8.83M +$4.45M +106,424 +94%
FT
23
Fiduciary Trust
Massachusetts
$8.61M
Northern Trust
24
Northern Trust
Illinois
$8.54M -$714K -17,070 -7%
CS
25
Candriam SCA
Luxembourg
$7.4M +$7.72M +184,396 New

MORF Hedge Fund Activity: Q1 2022 in Review

103 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Morphic Holding, Inc. Common Stock (MORF) for Q1 2022, worth a combined $1.13B — down 11% from $1.27B a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of MORF and 15 opened new positions — a net loss of 9 holders — while 38 trimmed existing stakes and 33 added.

The largest buyer was Holocene Advisors, adding an estimated $18.7M. The largest seller was Novo Holdings A/S, cutting an estimated $17.4M.

  • 103 institutional investors held Morphic Holding, Inc. Common Stock (MORF) as of Q1 2022, down from 113 in Q4 2021.
  • Funds reported $1.13B of Morphic Holding, Inc. Common Stock stock for Q1 2022, down 11% quarter-over-quarter.
  • 15 funds opened new Morphic Holding, Inc. Common Stock positions in Q1 2022 and 24 closed out, a net change of -9 holders.
  • The largest Morphic Holding, Inc. Common Stock buyer in Q1 2022 was Holocene Advisors, an estimated $18.7M added.
  • The largest Morphic Holding, Inc. Common Stock seller in Q1 2022 was Novo Holdings A/S, an estimated $17.4M sold.

Based on aggregated 13F filings for Q1 2022.